ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 227 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2 | 0.0% | 530 | 0.0% | 0.00% | – |
Q1 2024 | $2 | -33.3% | 530 | 0.0% | 0.00% | – |
Q4 2023 | $3 | 0.0% | 530 | 0.0% | 0.00% | – |
Q3 2023 | $3 | -25.0% | 530 | 0.0% | 0.00% | – |
Q2 2023 | $4 | -20.0% | 530 | 0.0% | 0.00% | – |
Q1 2023 | $5 | +25.0% | 530 | 0.0% | 0.00% | – |
Q4 2022 | $4 | -99.9% | 530 | 0.0% | 0.00% | – |
Q3 2022 | $4,000 | 0.0% | 530 | 0.0% | 0.00% | – |
Q2 2022 | $4,000 | -33.3% | 530 | +28.6% | 0.00% | – |
Q1 2022 | $6,000 | -50.0% | 412 | 0.0% | 0.00% | – |
Q4 2021 | $12,000 | -25.0% | 412 | -14.5% | 0.00% | – |
Q3 2021 | $16,000 | +45.5% | 482 | +74.6% | 0.00% | – |
Q2 2021 | $11,000 | 0.0% | 276 | 0.0% | 0.00% | – |
Q1 2021 | $11,000 | -26.7% | 276 | +7.4% | 0.00% | – |
Q4 2020 | $15,000 | -57.1% | 257 | -64.5% | 0.00% | – |
Q3 2020 | $35,000 | +75.0% | 723 | +3.0% | 0.00% | – |
Q2 2020 | $20,000 | 0.0% | 702 | 0.0% | 0.00% | – |
Q1 2020 | $20,000 | -4.8% | 702 | 0.0% | 0.00% | – |
Q4 2019 | $21,000 | – | 702 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 1,687,665 | $5,417,405 | 5.10% |
Rubric Capital Management LP | 10,500,000 | $33,705,000 | 1.00% |
Triatomic Management LP | 98,555 | $316,362 | 0.59% |
Pier Capital, LLC | 1,103,441 | $3,542,046 | 0.49% |
Newtyn Management, LLC | 623,690 | $2,002,045 | 0.40% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $96,279,803 | 0.36% |
Matrix Capital Management Company, LP | 11,572,590 | $37,148,014 | 0.34% |
Tejara Capital Ltd | 269,014 | $863,535 | 0.32% |
Aristotle Atlantic Partners, LLC | 2,992,563 | $9,606,127 | 0.31% |
DDD Partners, LLC | 739,739 | $2,374,562 | 0.29% |